Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 6

1.

A phase 2 clinical trial of metformin as a treatment for non-diabetic paediatric non-alcoholic steatohepatitis.

Schwimmer JB, Middleton MS, Deutsch R, Lavine JE.

Aliment Pharmacol Ther. 2005 Apr 1;21(7):871-9.

2.

Review article: epidemiology, pathogenesis and potential treatments of paediatric non-alcoholic fatty liver disease.

Barshop NJ, Sirlin CB, Schwimmer JB, Lavine JE.

Aliment Pharmacol Ther. 2008 Jul;28(1):13-24. doi: 10.1111/j.1365-2036.2008.03703.x. Epub 2008 Apr 4. Review.

3.

Metformin in the treatment of non-alcoholic fatty liver disease: safety, efficacy and mechanism.

Rouabhia S, Milic N, Abenavoli L.

Expert Rev Gastroenterol Hepatol. 2014 May;8(4):343-9. doi: 10.1586/17474124.2014.894880. Epub 2014 Mar 3. Review.

PMID:
24580044
4.

Therapeutic trials in nonalcoholic steatohepatitis: insulin sensitizers and related methodological issues.

Ratziu V, Caldwell S, Neuschwander-Tetri BA.

Hepatology. 2010 Dec;52(6):2206-15. doi: 10.1002/hep.24042. Review.

PMID:
21105109
5.

Non-alcoholic fatty liver disease/non-alcoholic steatohepatitis (NAFLD/NASH): treatment.

Bugianesi E, Marzocchi R, Villanova N, Marchesini G.

Best Pract Res Clin Gastroenterol. 2004 Dec;18(6):1105-16. Review.

PMID:
15561641
6.

[Treatment of non-alcoholic steatohepatitis].

Fehér J, Hagymási K.

Orv Hetil. 2004 Mar 21;145(12):631-4. Review. Hungarian. No abstract available.

PMID:
15119118

Supplemental Content

Support Center